Concepedia

Rajni Sinha

RS

Statistics

Publications

30

Citations

2.6K

H-Index

20

Active since

2008

Affiliations

Emory University(Current)

Piedmont Cancer Institute

Winship Cancer Institute

University of Rochester

Mayo Clinic in Florida

Rajni Sinha is an author at Emory University specializing in oncology, medicine, and hematologic oncology.

Publications per year

2008–2023

30

Publications

30

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Jonathan W. Friedberg, Jeff P. Sharman, John Sweetenham et al. · Blood · 2009 · 739 citations · Full text

Medicine, Oncology, Pharmacology +10

Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study

André Goy, Rajni Sinha, Michael E. Williams et al. · Journal of Clinical Oncology · 2013 · 349 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial

Fabrice André, Yeon Hee Park, Sung‐Bae Kim et al. · The Lancet · 2023 · 345 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma

Wei-Gang Tong, Rong Chen, William Plunkett et al. · Journal of Clinical Oncology · 2010 · 218 citations

Medicine, Oncology, Pharmacology +17

Racial differences in the presentation and outcomes of diffuse large B‐cell lymphoma in the United States

Pareen J. Shenoy, Neha Malik, Ajay K. Nooka et al. · Cancer · 2010 · 156 citations · Full text

Medicine, Hematology, Oncology +15

1–5 of 30